Arcus Biosciences stock price
아쿠스 바이오사이언시스NYSE:RCUS · New York Stock Exchange · HealthcareToday's signals · MACD bullish cross
Signal details →Arcus Biosciences last closed at $24.44 (-3.13%) on 2026-10-02. Signals today: MACD bullish cross. Listed on New York Stock Exchange. Trailing 12 months PER is -6.8×. Its overall grade ranks 562 of 739 stocks in Healthcare.
About this company
Arcus Biosciences last closed at $24.44 (-3.13%) on 2026-10-02. Signals today: MACD bullish cross. Listed on New York Stock Exchange.
Details →Reported results
Position in sector
Healthcare · Overall C · 562/739
Valuation grade B-
Related stocks
- Gilead SciencesCustomer
아코스와의 공동개발·라이선스 협력으로 주요 파트너
- TIGIT 관련 면역항암 개발사Competitor
TIGIT 면역항암제 개발 경쟁 테마
- Merck & Co.Competitor
면역항암제·병용요법 시장의 대형 경쟁사
About Arcus Biosciences
- What technical signals does Arcus Biosciences (RCUS) have?
- Arcus Biosciences current technical signals: MACD bullish cross.
- Is Arcus Biosciences a cup-and-handle pattern?
- No. Arcus Biosciences has no valid Cup signal right now.
- What published figures are available for Arcus Biosciences?
- Market cap: $3B. Trailing 12 months PER: -6.8×. Latest quarter PBR: 6.64×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-04 dataset
Turn what you saw on this name into a strategy
Ask Q about Arcus Biosciences, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).